Innovative Industrial Properties (IIPR) is back in focus after investors learned of a class action lawsuit alleging misrepresentation of leasing profitability, along with a new US$20 million secured term loan that changes its debt profile.

Recent headlines around the class action filing and the new US$20 million secured term loan come after a period where the stock shows a 30 day share price return of 8.52% and a 1 year total shareholder return of 15.22%. However, the 5 year total shareholder return remains negative and signals that longer term momentum has faded.

If this kind of legal and financing news has you rethinking where you look for income, it could be a good moment to broaden your watchlist with 13 dividend fortresses

So with a 1 year total return of 15.22% but a 5 year return that is still in the red, plus fresh legal and debt headlines, are you looking at an undervalued REIT or a stock where markets already price in future growth?

Most Popular Narrative: 39.5% Undervalued

With the current share price at $54.49 and the most followed narrative pointing to a $90 fair value, the gap between today’s price and those expectations is wide enough to make investors ask what is driving that thesis.

IIPR's bold strategic investment in IQHQ grants access to the booming life sciences real estate sector, particularly benefiting from growing demand in AI-driven biotech, paving the way for high-double-digit total returns, immediate AFFO accretion, and transformative portfolio diversification that could command premium multiples.

The story behind that $90 figure relies on specific calls about how fast revenues can build, how margins could reset, and what kind of earnings multiple investors might eventually accept. Want to see exactly which assumptions have to hold for this gap between price and narrative fair value to make sense.

Result: Fair Value of $90 (UNDERVALUED)

However, there are still meaningful risks, including ongoing tenant credit issues and uncertainty around cannabis regulation, that could easily derail the bullish assumptions.

Next Steps

With mixed signals across returns, litigation, and refinancing, the picture is far from one sided, so move quickly, review the details, and weigh 3 key rewards and 1 important warning sign

Looking for more investment ideas?

Do not stop with one stock story. Broaden your opportunity set now using focused screens that can surface income, value, and resilience before others catch on.

• Target steadier income by reviewing companies in the 13 dividend fortresses that may suit a yield focused portfolio.
• Hunt for potential bargains by scanning the 49 high quality undervalued stocks that some investors may be overlooking.
• Prioritize resilience by assessing companies in the 72 resilient stocks with low risk scores that score well on risk factors you care about.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.